In the cancer cell lines in the CCLE database, DLAT expression was relatively high in adrenal cancer, malignant rhabdoid tumor, and lung cancer and relatively low in kidney cancer, liposarcoma, and head and neck cancer (Figure 5B). This evidence concerns the gene DLAT and cancer.